GB1497407A - Therapeutic compositions - Google Patents
Therapeutic compositionsInfo
- Publication number
- GB1497407A GB1497407A GB17500/77A GB1750077A GB1497407A GB 1497407 A GB1497407 A GB 1497407A GB 17500/77 A GB17500/77 A GB 17500/77A GB 1750077 A GB1750077 A GB 1750077A GB 1497407 A GB1497407 A GB 1497407A
- Authority
- GB
- United Kingdom
- Prior art keywords
- site
- produce
- carbon atoms
- residue
- available hydroxyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 2
- 125000004036 acetal group Chemical group 0.000 abstract 2
- 230000000840 anti-viral effect Effects 0.000 abstract 2
- 150000002771 monosaccharide derivatives Chemical class 0.000 abstract 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 abstract 1
- 150000001299 aldehydes Chemical class 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 125000004185 ester group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002386 heptoses Chemical class 0.000 abstract 1
- 150000002402 hexoses Chemical class 0.000 abstract 1
- -1 inorganic acid salts Chemical class 0.000 abstract 1
- 150000002576 ketones Chemical class 0.000 abstract 1
- 150000002772 monosaccharides Chemical class 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 150000002972 pentoses Chemical class 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 235000020357 syrup Nutrition 0.000 abstract 1
- 239000006188 syrup Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/424,786 US3939146A (en) | 1973-03-01 | 1973-12-14 | Novel ethereal monosubstitutions of monosaccharide derivatives |
| AU44869/79A AU533108B2 (en) | 1973-12-14 | 1979-03-07 | Etherfied monosaccharides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1497407A true GB1497407A (en) | 1978-01-12 |
Family
ID=25626947
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB17500/77A Expired GB1497407A (en) | 1973-12-14 | 1974-12-13 | Therapeutic compositions |
| GB53972/74A Expired GB1497406A (en) | 1973-12-14 | 1974-12-13 | Ethereal monosubstitutions of monosaccharide derivatives |
| GB17502/77A Expired GB1497409A (en) | 1973-12-14 | 1974-12-13 | Method of therapeutically treating metastatic cancers |
| GB17501/77A Expired GB1497408A (en) | 1973-12-14 | 1974-12-13 | Method for increasing the life span of tissue culture cells |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB53972/74A Expired GB1497406A (en) | 1973-12-14 | 1974-12-13 | Ethereal monosubstitutions of monosaccharide derivatives |
| GB17502/77A Expired GB1497409A (en) | 1973-12-14 | 1974-12-13 | Method of therapeutically treating metastatic cancers |
| GB17501/77A Expired GB1497408A (en) | 1973-12-14 | 1974-12-13 | Method for increasing the life span of tissue culture cells |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JPS5619877B2 (cs) |
| AT (1) | AT352145B (cs) |
| AU (1) | AU533108B2 (cs) |
| BE (1) | BE823313A (cs) |
| CA (1) | CA1030960A (cs) |
| CH (1) | CH606073A5 (cs) |
| DD (1) | DD116029A5 (cs) |
| DE (1) | DE2455026A1 (cs) |
| FR (1) | FR2254348B2 (cs) |
| GB (4) | GB1497407A (cs) |
| IN (2) | IN141230B (cs) |
| SE (1) | SE7415662L (cs) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1227276A (en) * | 1975-03-28 | 1977-09-29 | Strategic Medical Res Corp | Ethers of monosaccarides |
| DE3812181A1 (de) * | 1988-04-13 | 1989-10-26 | Werner E G Prof Dr Mueller | Arzneimittel, enthaltend natuerliche und/oder chemisch modifizierte mono- oder polysaccharide und deren verwendung |
| US4996195A (en) * | 1989-01-09 | 1991-02-26 | Greenwich Pharmaceuticals Inc. | Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives |
| US5010058A (en) * | 1989-06-22 | 1991-04-23 | 501 Greenwich Pharmaceuticals Incorporated | 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives |
| US20020165168A1 (en) * | 1995-12-16 | 2002-11-07 | Joachim Bunger | Use of sugar derivatives as antimicrobial, antimycotic and/or antiviral active substances |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1793336C3 (de) * | 1967-09-11 | 1974-10-03 | Ciba-Geigy Ag, Basel (Schweiz) | D-Glucofuranoside, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate |
| JPS5118195B2 (cs) * | 1972-06-19 | 1976-06-08 | ||
| US3939145A (en) * | 1973-03-01 | 1976-02-17 | Strategic Medical Research Corporation | Novel ethereally monosubstituted monosaccharides |
-
1974
- 1974-11-05 IN IN2430/CAL/74A patent/IN141230B/en unknown
- 1974-11-20 DE DE19742455026 patent/DE2455026A1/de active Granted
- 1974-12-12 AT AT989874A patent/AT352145B/de not_active IP Right Cessation
- 1974-12-13 CA CA215,984A patent/CA1030960A/en not_active Expired
- 1974-12-13 GB GB17500/77A patent/GB1497407A/en not_active Expired
- 1974-12-13 CH CH1662074A patent/CH606073A5/xx not_active IP Right Cessation
- 1974-12-13 FR FR7441136A patent/FR2254348B2/fr not_active Expired
- 1974-12-13 GB GB53972/74A patent/GB1497406A/en not_active Expired
- 1974-12-13 BE BE151468A patent/BE823313A/xx not_active IP Right Cessation
- 1974-12-13 GB GB17502/77A patent/GB1497409A/en not_active Expired
- 1974-12-13 GB GB17501/77A patent/GB1497408A/en not_active Expired
- 1974-12-13 DD DD182997A patent/DD116029A5/xx unknown
- 1974-12-13 SE SE7415662A patent/SE7415662L/xx unknown
- 1974-12-14 JP JP14308974A patent/JPS5619877B2/ja not_active Expired
-
1976
- 1976-03-20 IN IN496/CAL/1976A patent/IN144240B/en unknown
-
1979
- 1979-03-07 AU AU44869/79A patent/AU533108B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| BE823313A (fr) | 1975-06-13 |
| JPS5093909A (cs) | 1975-07-26 |
| IN141230B (cs) | 1977-02-05 |
| GB1497406A (en) | 1978-01-12 |
| JPS5619877B2 (cs) | 1981-05-09 |
| AT352145B (de) | 1979-09-10 |
| DE2455026A1 (de) | 1975-07-03 |
| ATA989874A (de) | 1979-02-15 |
| IN144240B (cs) | 1978-04-15 |
| DE2455026C2 (cs) | 1988-02-25 |
| SE7415662L (cs) | 1975-06-16 |
| CH606073A5 (cs) | 1978-10-13 |
| DD116029A5 (cs) | 1975-11-05 |
| AU533108B2 (en) | 1983-11-03 |
| FR2254348A2 (cs) | 1975-07-11 |
| GB1497409A (en) | 1978-01-12 |
| CA1030960A (en) | 1978-05-09 |
| AU7611374A (en) | 1976-06-10 |
| GB1497408A (en) | 1978-01-12 |
| FR2254348B2 (cs) | 1980-03-21 |
| AU4486979A (en) | 1979-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR880000370A (ko) | 치환된 페닐화합물 | |
| KR890016036A (ko) | 아스코르브산 2-포스페이트 에스테르 | |
| KR940001886A (ko) | B형 간염 바이러스(hbv)의 복제를 억제하는 약학적 제제 | |
| KR950032262A (ko) | 프로피오페논 유도체 및 이의 제조방법 | |
| ES456567A1 (es) | Procedimiento para la preparacion de nuevos derivados de e- ritromicina. | |
| KR900015718A (ko) | 골관절염 치료제 | |
| NO178923C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 24-homo-vitamin-D-derivater | |
| SE8303013D0 (sv) | B-gamma-dihydropolyprenylalkoholderivat och farmaceutisk komposition innehallande en polyprenylforening | |
| SE8703032L (sv) | Perkutan administrering av lekemedel | |
| GB1497407A (en) | Therapeutic compositions | |
| FR2649110B1 (fr) | Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| KR910700230A (ko) | 신규 히드록실아민 유도체 | |
| ES346177A1 (es) | Procedimiento para la preparacion de epipodofilotoxina - bencilideno - d-glucosido. | |
| KR880007080A (ko) | 제약학적 생성물 | |
| ES420628A1 (es) | Procedimiento para la preparacion de n-(furiu-metil)-morfi-nanos. | |
| KR860008962A (ko) | 테르펜 유도체의 제조방법 | |
| KR890008063A (ko) | 소염제로서 유용한 3급-부틸페닐 화합물 | |
| DE69103087D1 (de) | N-substituierte Trifluormethylphenyltetrahydropyridine, Verfahren zur Herstellung, Zwischenprodukte, sowie Arzneimittel, die solche enthalten. | |
| KR910004557A (ko) | 2,4,6-치환 페놀 유도체 | |
| KR890009401A (ko) | 바이러스를 억제시키는 방법 | |
| FR2681864B1 (fr) | Nouveaux derives bicycliques azotes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. | |
| PT90813A (pt) | Processo de preparacao de derivados da fenotiazina e de composicoes farmaceuticas que os contem | |
| GB1434074A (en) | Antiviral compositions comprising hydantoin derivatives | |
| IE35575B1 (en) | Anthelmintic ethers and formulations thereof | |
| GB1508338A (en) | Pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PE20 | Patent expired after termination of 20 years |
Effective date: 19941212 |